NCT01476124View on ClinicalTrials.gov

Drug Drug Interaction Study With Gabapentin Enacarbil and Morphine

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Restless Legs Syndrome
Interventions
DRUG

morphine Placebo

Morphine Placebo

DRUG

GEn 600 mg

Gabapentin enacarbil 600 mg

DRUG

Morphine

morphine extended release 60 mg

DRUG

GEn Placebo

Gabapentin enacarbil placebo

Trial Locations (1)

78744

GSK Investigational Site, Austin

All Listed Sponsors
lead

XenoPort, Inc.

INDUSTRY

NCT01476124 - Drug Drug Interaction Study With Gabapentin Enacarbil and Morphine | Biotech Hunter | Biotech Hunter